Economic Consequences of the Overuse of Short-Acting ß-Adrenergic Agonists in the Treatment of Asthma in Spain
Antonio Valero, Vicente Plaza(Hospital de Sant Pau), Stacey L. Simon(Children's Hospital Colorado), Margarita Capel(AstraZeneca (Spain)), Aram Sicras-Navarro(Health Economics and Outcomes Research (United Kingdom)), Javier Nuevo(AstraZeneca (Spain)), Antoni Sicras‐Mainar(Health Economics and Outcomes Research (United Kingdom))
Cited by 7
Related Papers
Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea
|Clinical Infectious Diseases|2006|204
Correlates of Pediatric CPAP Adherence
|Journal of Clinical Sleep Medicine|2016|104
Morning Circadian Misalignment Is Associated With Insulin Resistance in Girls With Obesity and Polycystic Ovarian Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2019|87